Literature DB >> 18179800

BMP-2 promotes phosphate uptake, phenotypic modulation, and calcification of human vascular smooth muscle cells.

Xianwu Li1, Hsueh-Ying Yang, Cecilia M Giachelli.   

Abstract

Vascular calcification is associated with increased risk of cardiovascular events that are the most common cause of death in patients with end-stage renal disease. Clinical and experimental studies indicate that hyperphosphatemia is a risk factor for vascular calcification and cardiovascular mortality in these patients. Our previous studies demonstrated that phosphate transport through the type III sodium-dependent phosphate cotransporter, Pit-1, was necessary for phosphate-induced calcification and osteochondrogenic phenotypic change in cultured human smooth muscle cells (SMC). BMP-2 is a potent osteogenic protein required for osteoblast differentiation and bone formation that has been implicated in vascular calcification. In the present study, we have examined the effects of BMP-2 on human SMC calcification in vitro. We found that treatment of SMC with BMP-2 enhanced elevated phosphate-induced calcification, but did not induce calcification under normal phosphate conditions. mRNAs for BMP receptors, including ALK2, ALK3, ALK6, BMPR-II, ActR-IIA and ActR-IIB were all detected in human SMCs. Mechanistically, BMP-2 dose-dependently stimulated phosphate uptake in SMC (200 ng/ml BMP-2 vs. vehicle: 13.94 vs. 7.09 nmol/30 min/mg protein, respectively). Real-time PCR and Western blot revealed the upregulation of Pit-1 mRNA and protein levels, respectively, by BMP-2. More importantly, inhibition of phosphate uptake by a competitive inhibitor of sodium-dependent phosphate cotransport, phosphonoformic acid, abrogated BMP-2-induced calcification. These results indicate that phosphate transport via Pit-1 is crucial in BMP-2-regulated SMC calcification. In addition, BMP-2-induced Runx2 and inhibited SM22 expression, indicating that it promotes osteogenic phenotype transition in these cells. Thus, BMP-2 may promote vascular calcification via increased phosphate uptake and induction of osteogenic phenotype modulation in SMC.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18179800      PMCID: PMC3249145          DOI: 10.1016/j.atherosclerosis.2007.11.031

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  32 in total

1.  Transforming growth factor-beta stimulates inorganic phosphate transport and expression of the type III phosphate transporter Glvr-1 in chondrogenic ATDC5 cells.

Authors:  G Palmer; J Guicheux; J P Bonjour; J Caverzasio
Journal:  Endocrinology       Date:  2000-06       Impact factor: 4.736

2.  Matrix GLA protein, a regulatory protein for bone morphogenetic protein-2.

Authors:  Amina F Zebboudj; Minori Imura; Kristina Boström
Journal:  J Biol Chem       Date:  2001-12-06       Impact factor: 5.157

3.  Smooth muscle cell phenotypic transition associated with calcification: upregulation of Cbfa1 and downregulation of smooth muscle lineage markers.

Authors:  S A Steitz; M Y Speer; G Curinga; H Y Yang; P Haynes; R Aebersold; T Schinke; G Karsenty; C M Giachelli
Journal:  Circ Res       Date:  2001-12-07       Impact factor: 17.367

4.  Essential requirement of BMPs-2/4 for both osteoblast and osteoclast formation in murine bone marrow cultures from adult mice: antagonism by noggin.

Authors:  E Abe; M Yamamoto; Y Taguchi; B Lecka-Czernik; C A O'Brien; A N Economides; N Stahl; R L Jilka; S C Manolagas
Journal:  J Bone Miner Res       Date:  2000-04       Impact factor: 6.741

5.  Phosphorus and uremic serum up-regulate osteopontin expression in vascular smooth muscle cells.

Authors:  Neal X Chen; Kalisha D O'Neill; Danxia Duan; Sharon M Moe
Journal:  Kidney Int       Date:  2002-11       Impact factor: 10.612

6.  Tumor necrosis factor-alpha promotes in vitro calcification of vascular cells via the cAMP pathway.

Authors:  Y Tintut; J Patel; F Parhami; L L Demer
Journal:  Circulation       Date:  2000-11-21       Impact factor: 29.690

7.  MSX2 promotes osteogenesis and suppresses adipogenic differentiation of multipotent mesenchymal progenitors.

Authors:  Su-Li Cheng; Jian-Su Shao; Nichole Charlton-Kachigian; Arleen P Loewy; Dwight A Towler
Journal:  J Biol Chem       Date:  2003-08-18       Impact factor: 5.157

8.  Stimulation of BMP-2 expression by pro-inflammatory cytokines IL-1 and TNF-alpha in normal and osteoarthritic chondrocytes.

Authors:  Naoshi Fukui; Yong Zhu; William J Maloney; John Clohisy; Linda J Sandell
Journal:  J Bone Joint Surg Am       Date:  2003       Impact factor: 5.284

9.  Phosphate and calcium uptake by rat odontoblast-like MRPC-1 cells concomitant with mineralization.

Authors:  P Lundquist; H H Ritchie; K Moore; T Lundgren; A Linde
Journal:  J Bone Miner Res       Date:  2002-10       Impact factor: 6.741

10.  Matrix GLA protein and BMP-2 regulate osteoinduction in calcifying vascular cells.

Authors:  Amina F Zebboudj; Victoria Shin; Kristina Boström
Journal:  J Cell Biochem       Date:  2003-11-01       Impact factor: 4.429

View more
  106 in total

1.  Cholesterol in vascular and valvular calcification.

Authors:  L L Demer
Journal:  Circulation       Date:  2001-10-16       Impact factor: 29.690

2.  Osteoblast-like differentiation of cultured human coronary artery smooth muscle cells by bone morphogenetic protein endothelial cell precursor-derived regulator (BMPER).

Authors:  Seimi Satomi-Kobayashi; Mitsuo Kinugasa; Reiko Kobayashi; Kinta Hatakeyama; Yusuke Kurogane; Tatsuro Ishida; Noriaki Emoto; Yujiro Asada; Yoshimi Takai; Ken-ichi Hirata; Yoshiyuki Rikitake
Journal:  J Biol Chem       Date:  2012-07-09       Impact factor: 5.157

3.  Secreted Phosphoprotein 24 is a Biomarker of Mineral Metabolism.

Authors:  Mandy E Turner; Christine A White; Sarah M Taylor; Kathryn Neville; Karen Rees-Milton; Wilma M Hopman; Michael A Adams; Tassos Anastassiades; Rachel M Holden
Journal:  Calcif Tissue Int       Date:  2021-01-22       Impact factor: 4.333

Review 4.  Vascular calcification: pathobiology of a multifaceted disease.

Authors:  Linda L Demer; Yin Tintut
Journal:  Circulation       Date:  2008-06-03       Impact factor: 29.690

Review 5.  Angiotensin II and vascular injury.

Authors:  Augusto C Montezano; Aurelie Nguyen Dinh Cat; Francisco J Rios; Rhian M Touyz
Journal:  Curr Hypertens Rep       Date:  2014-06       Impact factor: 5.369

Review 6.  Arterial calcification: Finger-pointing at resident and circulating stem cells.

Authors:  Francesco Vasuri; Silvia Fittipaldi; Gianandrea Pasquinelli
Journal:  World J Stem Cells       Date:  2014-11-26       Impact factor: 5.326

7.  Comparison of echocardiographic changes in children with primary hypertension and hypertension due to mild to moderate chronic kidney disease.

Authors:  Gabriel Paris; Sudheer R Gorla; Aura J Arenas-Morales; Wacharee Seeherunvong; Sethuraman Swaminathan
Journal:  Pediatr Nephrol       Date:  2018-10-01       Impact factor: 3.714

8.  Regulation of vascular smooth muscle cell calcification by extracellular pyrophosphate homeostasis: synergistic modulation by cyclic AMP and hyperphosphatemia.

Authors:  Domenick A Prosdocimo; Steven C Wyler; Andrea M Romani; W Charles O'Neill; George R Dubyak
Journal:  Am J Physiol Cell Physiol       Date:  2009-12-16       Impact factor: 4.249

Review 9.  The emerging role of phosphate in vascular calcification.

Authors:  Cecilia M Giachelli
Journal:  Kidney Int       Date:  2009-01-14       Impact factor: 10.612

10.  MicroRNA in cardiovascular calcification: focus on targets and extracellular vesicle delivery mechanisms.

Authors:  Claudia Goettsch; Joshua D Hutcheson; Elena Aikawa
Journal:  Circ Res       Date:  2013-03-29       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.